| ■ 영문 제목 : Global Natamycin Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02103 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 106 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 나타마이신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (포도당 베이스, 유당 베이스, 염화나트륨 베이스)와 용도별 시장규모 (식품, 의료, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 나타마이신 시장 점유율 - 지역별 나타마이신 시장규모 - 주요지역의 종류별 시장규모 (포도당 베이스, 유당 베이스, 염화나트륨 베이스) - 주요지역의 용도별 시장규모 (식품, 의료, 기타) - 미주의 나타마이신 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 나타마이신 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 나타마이신 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 나타마이신 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 나타마이신 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Danisco, DSM, VGP, Handary, AMTECH BIOTECH, Silver-Elephant, Lanzhou Weiri, Langfang Meihua, Zhengzhou New Frey, Chihon, Jiaozuo Joincare, Beijing Oriental Rada, Pucheng Lifecome - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Natamycin will have significant change from previous year. By the most conservative estimates of global Natamycin market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 170.2 million in 2020. Over the next five years the Natamycin market will register a 6.6% CAGR in terms of revenue, the global market size will reach US$ 220.1 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Natamycin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Glucose-based
Lactose-based
Sodium chloride-based
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Food
Medical
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Danisco
DSM
VGP
Handary
AMTECH BIOTECH
Silver-Elephant
Lanzhou Weiri
Langfang Meihua
Zhengzhou New Frey
Chihon
Jiaozuo Joincare
Beijing Oriental Rada
Pucheng Lifecome
1 Scope of the Report 2 Executive Summary 3 Global Natamycin by Company 4 Natamycin by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Natamycin Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Natamycin Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Glucose-based Table 3. Major Players of Lactose-based Table 4. Major Players of Sodium chloride-based Table 5. Global Natamycin Sales by Type (2016-2021) & (MT) Table 6. Global Natamycin Sales Market Share by Type (2016-2021) Table 7. Global Natamycin Revenue by Type (2016-2021) & ($ million) Table 8. Global Natamycin Revenue Market Share by Type (2016-2021) Table 9. Global Natamycin Sale Price by Type (2016-2021) Table 10. Global Natamycin Sales by Application (2016-2021) & (MT) Table 11. Global Natamycin Sales Market Share by Application (2016-2021) Table 12. Global Natamycin Value by Application (2016-2021) Table 13. Global Natamycin Revenue Market Share by Application (2016-2021) Table 14. Global Natamycin Sale Price by Application (2016-2021) Table 15. Global Natamycin Sales by Company (2019-2021) & (MT) Table 16. Global Natamycin Sales Market Share by Company (2019-2021) Table 17. Global Natamycin Revenue by Company (2019-2021) ($ Millions) Table 18. Global Natamycin Revenue Market Share by Company (2019-2021) Table 19. Global Natamycin Sale Price by Company (2019-2021) Table 20. Key Manufacturers Natamycin Producing Area Distribution and Sales Area Table 21. Players Natamycin Products Offered Table 22. Natamycin Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Natamycin Sales by Region (2016-2021) (MT) Table 26. Global Natamycin Sales Market Share by Region (2016-2021) Table 27. Global Natamycin Revenue by Region (2016-2021) & ($ Millions) Table 28. Global Natamycin Revenue Market Share by Region (2016-2021) Table 29. Americas Natamycin Sales by Country (2016-2021) & (MT) Table 30. Americas Natamycin Sales Market Share by Country (2016-2021) Table 31. Americas Natamycin Revenue by Country (2016-2021) & ($ Millions) Table 32. Americas Natamycin Revenue Market Share by Country (2016-2021) Table 33. Americas Natamycin Sales by Type (2016-2021) & (MT) Table 34. Americas Natamycin Sales Market Share by Type (2016-2021) Table 35. Americas Natamycin Sales by Application (2016-2021) & (MT) Table 36. Americas Natamycin Sales Market Share by Application (2016-2021) Table 37. APAC Natamycin Sales by Region (2016-2021) & (MT) Table 38. APAC Natamycin Sales Market Share by Region (2016-2021) Table 39. APAC Natamycin Revenue by Region (2016-2021) & ($ Millions) Table 40. APAC Natamycin Revenue Market Share by Region (2016-2021) Table 41. APAC Natamycin Sales by Type (2016-2021) & (MT) Table 42. APAC Natamycin Sales Market Share by Type (2016-2021) Table 43. APAC Natamycin Sales by Application (2016-2021) & (MT) Table 44. APAC Natamycin Sales Market Share by Application (2016-2021) Table 45. Europe Natamycin Sales by Country (2016-2021) & (MT) Table 46. Europe Natamycin Sales Market Share by Country (2016-2021) Table 47. Europe Natamycin Revenue by Country (2016-2021) & ($ Millions) Table 48. Europe Natamycin Revenue Market Share by Country (2016-2021) Table 49. Europe Natamycin Sales by Type (2016-2021) & (MT) Table 50. Europe Natamycin Sales Market Share by Type (2016-2021) Table 51. Europe Natamycin Sales by Application (2016-2021) & (MT) Table 52. Europe Natamycin Sales Market Share by Application (2016-2021) Table 53. Middle East & Africa Natamycin Sales by Country (2016-2021) & (MT) Table 54. Middle East & Africa Natamycin Sales Market Share by Country (2016-2021) Table 55. Middle East & Africa Natamycin Revenue by Country (2016-2021) & ($ Millions) Table 56. Middle East & Africa Natamycin Revenue Market Share by Country (2016-2021) Table 57. Middle East & Africa Natamycin Sales by Type (2016-2021) & (MT) Table 58. Middle East & Africa Natamycin Sales Market Share by Type (2016-2021) Table 59. Middle East & Africa Natamycin Sales by Application (2016-2021) & (MT) Table 60. Middle East & Africa Natamycin Sales Market Share by Application (2016-2021) Table 61. Key and Potential Regions of Natamycin Table 62. Key Application and Potential Industries of Natamycin Table 63. Key Challenges of Natamycin Table 64. Key Trends of Natamycin Table 65. Natamycin Distributors List Table 66. Natamycin Customer List Table 67. Global Natamycin Sales Forecast by Region (2021-2026) & (MT) Table 68. Global Natamycin Consumption Market Forecast by Region Table 69. Global Natamycin Revenue Forecast by Region (2021-2026) & ($ millions) Table 70. Global Natamycin Revenue Market Share Forecast by Region (2021-2026) Table 71. Americas Natamycin Sales Forecast by Country (2021-2026) & (MT) Table 72. Americas Natamycin Revenue Forecast by Country (2021-2026) & ($ millions) Table 73. APAC Natamycin Sales Forecast by Region (2021-2026) & (MT) Table 74. APAC Natamycin Revenue Forecast by Region (2021-2026) & ($ millions) Table 75. Europe Natamycin Sales Forecast by Country (2021-2026) & (MT) Table 76. Europe Natamycin Revenue Forecast by Country (2021-2026) & ($ millions) Table 77. Middle East & Africa Natamycin Sales Forecast by Country (2021-2026) & (MT) Table 78. Middle East & Africa Natamycin Revenue Forecast by Country (2021-2026) & ($ millions) Table 79. Global Natamycin Sales Forecast by Type (2021-2026) & (MT) Table 80. Global Natamycin Sales Market Share Forecast by Type (2021-2026) Table 81. Global Natamycin Revenue Forecast by Type (2021-2026) & ($ Millions) Table 82. Global Natamycin Revenue Market Share Forecast by Type (2021-2026) Table 83. Global Natamycin Sales Forecast by Application (2021-2026) & (MT) Table 84. Global Natamycin Sales Market Share Forecast by Application (2021-2026) Table 85. Global Natamycin Revenue Forecast by Application (2021-2026) & ($ Millions) Table 86. Global Natamycin Revenue Market Share Forecast by Application (2021-2026) Table 87. Danisco Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors Table 88. Danisco Natamycin Product Offered Table 89. Danisco Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E) Table 90. Danisco Main Business Table 91. Danisco Latest Developments Table 92. DSM Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors Table 93. DSM Natamycin Product Offered Table 94. DSM Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E) Table 95. DSM Main Business Table 96. DSM Latest Developments Table 97. VGP Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors Table 98. VGP Natamycin Product Offered Table 99. VGP Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E) Table 100. VGP Main Business Table 101. VGP Latest Developments Table 102. Handary Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors Table 103. Handary Natamycin Product Offered Table 104. Handary Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E) Table 105. Handary Main Business Table 106. Handary Latest Developments Table 107. AMTECH BIOTECH Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors Table 108. AMTECH BIOTECH Natamycin Product Offered Table 109. AMTECH BIOTECH Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E) Table 110. AMTECH BIOTECH Main Business Table 111. AMTECH BIOTECH Latest Developments Table 112. Silver-Elephant Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors Table 113. Silver-Elephant Natamycin Product Offered Table 114. Silver-Elephant Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E) Table 115. Silver-Elephant Main Business Table 116. Silver-Elephant Latest Developments Table 117. Lanzhou Weiri Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors Table 118. Lanzhou Weiri Natamycin Product Offered Table 119. Lanzhou Weiri Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E) Table 120. Lanzhou Weiri Main Business Table 121. Lanzhou Weiri Latest Developments Table 122. Langfang Meihua Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors Table 123. Langfang Meihua Natamycin Product Offered Table 124. Langfang Meihua Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E) Table 125. Langfang Meihua Main Business Table 126. Langfang Meihua Latest Developments Table 127. Zhengzhou New Frey Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors Table 128. Zhengzhou New Frey Natamycin Product Offered Table 129. Zhengzhou New Frey Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E) Table 130. Zhengzhou New Frey Main Business Table 131. Zhengzhou New Frey Latest Developments Table 132. Chihon Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors Table 133. Chihon Natamycin Product Offered Table 134. Chihon Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E) Table 135. Chihon Main Business Table 136. Chihon Latest Developments Table 137. Jiaozuo Joincare Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors Table 138. Jiaozuo Joincare Natamycin Product Offered Table 139. Jiaozuo Joincare Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E) Table 140. Jiaozuo Joincare Main Business Table 141. Jiaozuo Joincare Latest Developments Table 142. Beijing Oriental Rada Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors Table 143. Beijing Oriental Rada Natamycin Product Offered Table 144. Beijing Oriental Rada Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E) Table 145. Beijing Oriental Rada Main Business Table 146. Beijing Oriental Rada Latest Developments Table 147. Pucheng Lifecome Basic Information, Natamycin Manufacturing Base, Sales Area and Its Competitors Table 148. Pucheng Lifecome Natamycin Product Offered Table 149. Pucheng Lifecome Natamycin Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E) Table 150. Pucheng Lifecome Main Business Table 151. Pucheng Lifecome Latest Developments List of Figures Figure 1. Picture of Natamycin Figure 2. Natamycin Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Natamycin Sales Growth Rate 2016-2026 (MT) Figure 7. Global Natamycin Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Natamycin Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Glucose-based Figure 10. Product Picture of Lactose-based Figure 11. Product Picture of Sodium chloride-based Figure 12. Global Natamycin Sales Market Share by Type in 2020 Figure 13. Global Natamycin Revenue Market Share by Type (2016-2021) Figure 14. Natamycin Consumed in Food Figure 15. Global Natamycin Market: Food (2016-2021) & (MT) Figure 16. Natamycin Consumed in Medical Figure 17. Global Natamycin Market: Medical (2016-2021) & (MT) Figure 18. Natamycin Consumed in Others Figure 19. Global Natamycin Market: Others (2016-2021) & (MT) Figure 20. Global Natamycin Sales Market Share by Application (2016-2021) Figure 21. Global Natamycin Revenue Market Share by Application in 2020 Figure 22. Natamycin Revenue Market by Company in 2020 ($ Million) Figure 23. Global Natamycin Revenue Market Share by Company in 2020 Figure 24. Global Natamycin Sales Market Share by Regions (2016-2021) Figure 25. Global Natamycin Revenue Market Share by Region in 2020 Figure 26. Americas Natamycin Sales 2016-2021 (MT) Figure 27. Americas Natamycin Revenue 2016-2021 ($ Millions) Figure 28. APAC Natamycin Sales 2016-2021 (MT) Figure 29. APAC Natamycin Revenue 2016-2021 ($ Millions) Figure 30. Europe Natamycin Sales 2016-2021 (MT) Figure 31. Europe Natamycin Revenue 2016-2021 ($ Millions) Figure 32. Middle East & Africa Natamycin Sales 2016-2021 (MT) Figure 33. Middle East & Africa Natamycin Revenue 2016-2021 ($ Millions) Figure 34. Americas Natamycin Sales Market Share by Country in 2020 Figure 35. Americas Natamycin Revenue Market Share by Country in 2020 Figure 36. Americas Natamycin Sales Market Share by Type in 2020 Figure 37. Americas Natamycin Sales Market Share by Application in 2020 Figure 38. United States Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 39. Canada Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 40. Mexico Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 41. Brazil Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 42. APAC Natamycin Sales Market Share by Region in 2020 Figure 43. APAC Natamycin Revenue Market Share by Regions in 2020 Figure 44. APAC Natamycin Sales Market Share by Type in 2020 Figure 45. APAC Natamycin Sales Market Share by Application in 2020 Figure 46. China Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 47. Japan Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 48. Korea Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 49. Southeast Asia Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 50. India Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 51. Australia Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 52. Europe Natamycin Sales Market Share by Country in 2020 Figure 53. Europe Natamycin Revenue Market Share by Country in 2020 Figure 54. Europe Natamycin Sales Market Share by Type in 2020 Figure 55. Europe Natamycin Sales Market Share by Application in 2020 Figure 56. Germany Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 57. France Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 58. UK Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 59. Italy Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 60. Russia Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 61. Middle East & Africa Natamycin Sales Market Share by Country in 2020 Figure 62. Middle East & Africa Natamycin Revenue Market Share by Country in 2020 Figure 63. Middle East & Africa Natamycin Sales Market Share by Type in 2020 Figure 64. Middle East & Africa Natamycin Sales Market Share by Application in 2020 Figure 65. Egypt Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 66. South Africa Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 67. Israel Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 68. Turkey Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 69. GCC Country Natamycin Revenue Growth 2016-2021 ($ Millions) Figure 70. Channels of Distribution Figure 71. Distributors Profiles |
| ※본 조사보고서 [세계의 나타마이신 시장예측 2021년-2026년] (코드 : LPI-2201K02103) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 나타마이신 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |